🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The prognosis for older individuals with acute myelogenous leukemia (AML) h...
Status
Completed
Location
University of Michigan Cancer Center
Start Date
2007-03
Trial ID
NCT00623935
Treatments Being Tested
This is a treatment guideline to allow routine clinical data to be collecte...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2013-01
Trial ID
NCT01685411
This clinical trial studies fludarabine phosphate and total-body radiation ...
Status
Completed
Location
University of Arizona Health Sciences Center
Start Date
2000-12
Trial ID
NCT00014235
This research study is assessing the feasibility of reduced intensity allog...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2017-05
Trial ID
NCT02724904
Treatments Being Tested
This study is an extension to younger patients of the currently ongoing nat...
Status
Completed
Location
Institut Paoli-Calmettes
Start Date
2017-09-19
Trial ID
NCT03595800
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as melphalan and fludarab...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-07
Trial ID
NCT00027560
RATIONALE: Peripheral stem cell transplantation may be able to replace immu...
Status
Completed
Location
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Start Date
1999-10
Trial ID
NCT00004904
The purpose of this study is to determine whether 5-Azacytidine priming bef...
Status
Completed
Location
Weill Cornell Medical College
Start Date
2015-02-13
Trial ID
NCT02497404
Treatments Being Tested
RATIONALE: Rasburicase may be an effective treatment for graft-versus-host ...
Status
Completed
Location
Massachusetts General Hospital
Start Date
2008-01
Trial ID
NCT00513474
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and radia...
Status
Completed
Location
City of Hope Comprehensive Cancer Center
Start Date
2005-02
Trial ID
NCT00110058